Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kligman formula with versus without melatonin for bilateral melasma
IRCT20191003044970N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of melatonin in melasma and Hyperpigmentation (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Melasma Area and Severity Index, Skin analyzer biometric features and 12 more. Started Aug 2025; status: completed.
02
Drugs
melatonin
03
Conditions
melasmaHyperpigmentation
Beyond the preview
Go deeper on IRCT20191003044970N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191003044970N1.